Quantcast

Latest Acetylcholine Stories

368802e689ea992f70a4767d2b62435a1
2008-11-18 09:25:18

Scientists have identified a relationship between two proteins in the brain that has links to both nicotine addiction and autism. The finding has led to speculation that existing drugs used to curb nicotine addiction might serve as the basis for potential therapies to alleviate the symptoms of autism. The discovery identified a defining role for a protein made by the neurexin-1 gene, which is located in brain cells and assists in connecting neurons as part of the brain's chemical...

2008-10-21 15:00:28

SARASOTA, Fla., Oct. 21 /PRNewswire/ -- A team of world-renowned scientists today announced the launch of Archer Pharmaceuticals, Inc., a new company that will use modern technologies for the identification of novel treatments for Alzheimer's disease. Archer Pharmaceuticals, Inc., led by Chief Executive Officer Michael Mullan, M.B.B.S., Ph.D. and Chief Technical Officer Fiona Crawford, Ph.D., was created based on the groundbreaking research that their team has been conducting in Florida...

2008-10-03 12:00:27

REYKJAVIK, Iceland, Oct. 3 /PRNewswire-FirstCall/ -- deCODE genetics today announced the filing of an investigational new drug (IND) application for DG071, the company's novel small-molecule modulator of phosphodiesterase 4 (PDE4), with the US Food and Drug Administration (FDA). The compound is being developed as a new and potentially safer means of targeting PDE4 to combat memory loss and cognitive deficits associated with Alzheimer's disease and other disorders in which neural signaling...

2008-10-01 15:00:50

U.S. biophysicists say they have clarified the mysterious interaction between cholesterol and the brain's neurotransmitter receptors. University of Pennsylvania scientists said they have provided a new model of behavior for the nicotinic acetylcholine receptor, a well studied protein involved in inflammation, Alzheimer's disease, Parkinson's disease, schizophrenia, epilepsy, the effect of general anesthetics and addiction to alcohol, nicotine and cocaine. As a result of the study,...

2008-09-11 12:00:43

Xel Pharmaceuticals has completed the development of its once-a-week Huperzine A transdermal patch for the treatment of Alzheimer's disease. The prototype transdermal patch can deliver 400800mcg of Huperzine A per day for up to seven days. Huperzine A is said to be a naturally occurring alkaloid found from the club moss Huperzia serrata that has been used for decades in China as a prescription medication for the treatment of dementia. It is a potent, highly selective and reversible...

2008-09-10 12:00:52

Xel Pharmaceuticals, Inc. announced today the completion of the development of its once-a-week Huperzine A transdermal patch for the treatment of Alzheimer's disease (AD). The prototype transdermal patch can deliver 400-800 mcg of Huperzine A per day for up to seven days. Huperzine A is a naturally occurring alkaloid found from the club moss Huperzia serrata that has been used for decades in China as a prescription medication for the treatment of dementia. Huperzine A is a potent, highly...

2008-09-10 06:00:08

TheraGenetics Limited, a personalized medicine diagnostics company that is developing and commercializing a portfolio of pharmacogenetic diagnostic tests to guide and improve the treatment of central nervous system (CNS) disorders, announced today an agreement with King's College London for its participation in the AddNeuroMed Consortium to identify biomarkers for Alzheimer's disease that can be used to determine patient response to medications. TheraGenetics will undertake a pharmacogenetic...

2008-08-20 09:00:22

SAN FRANCISCO, Aug. 20 /PRNewswire/ -- Emerging therapeutic strategies for Alzheimer's disease is the focus of the most recent edition of Neurotech Insights, the leading monthly industry newsletter covering drugs, devices and diagnostics for the brain and nervous system. This month's feature article reviews the competing hypotheses around the cause of Alzheimer's disease including: the beta amyloid theory, tau hypothesis, the APOE4 and vascular theory, anti-inflammatories, memory...

2008-08-11 12:01:06

Ford Motor, Automotive Components Holdings and Johnson Controls, have terminated their memorandum of understanding for sale of the Automotive Components Holdings's interiors business and Saline, Michigan plant, to Johnson Controls. The memorandum of understanding (MoU), which outlined the terms of the proposed acquisition, was signed in November 2007. The decision to terminate the MoU was reached by mutual consent. Automotive Components Holdings (ACH) is considering all options and no...

2008-07-09 15:00:35

Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT) today announced the publication of key research findings with its lead Alzheimer's Disease drug, PBT2. The article titled "Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxyquinoline analogs is associated with decreased interstitial Abeta" appears in the current edition of the prestigious scientific journal Neuron, and can be viewed online. The key findings reported are: -- PBT2 profoundly and rapidly...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related